Small Pharma (AgeTech UK) NeuroTech

Psychedelics for depression.Forging a new path in pharmaceutical development by bridging the gap between academia and industry. With specific experience in IP and the drug development process, they integrate a robust IP strategy with the development plan required to guide close-to-clinic candidates through the clinical trials necessary to demonstrate proof-of-concept in patients.

Founded Date: N/A
Headquarters: United Kingdom
Technology: AgeTech Companies
Employee Number: N/A
Industry: UK AgeTech 2020
Number Of Exists: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A